补肾化瘀方对多囊卵巢综合征大鼠血清25羟基维生素D3、AMH、T、INS及E2的影响
2018-09-10黄威鲁耀邦熊桦崔培梧
黄威 鲁耀邦 熊桦 崔培梧
〔摘要〕 目的 研究补肾化瘀方对多囊卵巢综合征(polycystic ovary syndrome,PCOS)模型大鼠血清25羟基维生素D3[25-(OH)VD3]、抗苗勒管激素(AMH)、血清睾酮(T)、胰岛素(INS)及雌二醇(E2)的影响。方法 61只SD雌性大鼠随机选取8只设为空白组,剩余大鼠采用来曲唑灌胃法建立PCOS大鼠模型。成模后大鼠随机分为模型组、中药组及西药组,给予相应药物干预后腹主动脉取血。采用酶联免疫吸附法测定药物干预后各组大鼠血清激素[25-(OH)VD3、AMH、T、INS、E2]含量,分析各组血清激素水平的差异。结果 空白组、中药组以及西药组的血清E2与25(OH)VD3浓度高于模型组,差异有统计学意义(P<0.05或P<0.01),而AMH与INS浓度均低于模型组,差异有统计学意义(P<0.05或P<0.01)。结论 补肾化瘀方对灌服来曲唑所致PCOS模型大鼠血清AMH、INS、25(OH)VD3与E2等激素水平有调节作用,能有效改善PCOS的无排卵、卵泡发育停滞及糖脂代谢紊乱等问题。
〔关键词〕 多囊卵巢综合征;25羟基维生素D3;抗苗勒管激素;睾酮;胰岛素;雌二醇
〔中图分类号〕R271;R285.5 〔文献标志码〕A 〔文章编号〕doi:10.3969/j.issn.1674-070X.2018.06.009
〔Abstract〕 Objective To study the effect of Bushen Huayu decoction on serum vitamin D3, adrenal medullary hyperplasia (AMH), testosterone (T), insulin (INS) and estradiol (E2) in polycystic ovary syndrome (PCOS) rats. Methods Eight rats were randomly selected from 61 SD female as the blank group. The remaining rats by gastric perfusion of letrozole were to establishment of PCOS rat models. After modeling, the rats were randomly divided into the model group, the Chinese medicine group and the Western medicine group. The blood of abdominal aorta was taken after the intervention of the corresponding drug intervention. The serum levels of 25(OH)VD3, AMH, T, INS, and E2 in each group after drug intervention were measured by enzyme-linked immunosorbent assay (ELISA). The difference of serum levels in each group was analyzed. Results The concentrations of serum E2 and 25(OH)VD3 in the blank group, the Chinese medicine group and the western medicine group were higher than those in the model group, the results were significantly different (P<0.05 or P<0.01). The serum AMH and INS concentrations in the three groups were lower than those in the model group, which were significantly different (P<0.05 or P<0.01). Conclusion Bushen Huayu decoction can regulate the levels of AMH, INS, 25 (OH)VD3 and E2 in the serum of letrozole-induced polycystic ovary syndrome(PCOS) rat models, which can effectively improve PCOS's anovulatory, follicular development stagnation and disorder of glycolipid metabolism.
〔Keywords〕 polycystic ovary syndrome; 25 (OH) VD3; anti-miillerian hormone; T; INS; E2
多囊卵巢綜合征(polycystic ovary syndrome,PCOS)已成为妇科临床常见内分泌及代谢紊乱性疾病。该病在育龄妇女中发病率为5%~10%,导致无排卵性不孕的机率为75%,目前其发病率呈现逐年上升的趋势[1]。补肾化瘀方为尤昭玲教授治疗PCOS患者的经验方,临床案例及动物实验均显示其能有效改善PCOS[2-3]。近年来,有研究表明PCOS患者的血清25(OH)VD3水平偏低[4],而抗苗勒管激素(AMH)水平是正常女性2~3倍[5]。本实验通过研究补肾化瘀方对PCOS模型大鼠血清25羟基维生素D3[25-(OH)VD3]、抗苗勒管激素(AMH)、睾酮(T)、雌二醇(E2)、胰岛素(INS)水平的影响,探讨补肾化瘀方改善PCOS的作用机制。
1 材料
1.1 仪器
TGL16M型高速低温离心机(湖南湘立科学仪器有限公司)、海尔-86 ℃超低温冰箱(海尔公司)、 SC-316(商流)冷藏冰箱(海尔公司)、ELx800酶标仪(美国宝特Bio-Tek公司)。
1.2 药品与试剂
来曲唑(批号:16113057,规……
